SCHEMBL17544157

SCHEMBL17544157

O=C(Nc1ccc2oc(-c3cccnc3)nc2c1)c1cnc2ccccc2n1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.71
HSD17B10 Q99714 4/20 0.71
NPSR1 Q6W5P4 2/20 0.71
MAPT P10636 13/20 0.68
ALDH1A1 P00352 8/20 0.68
L3MBTL1 Q9Y468 2/20 0.68
PTK2B Q14289 1/20 0.68
NPC1 O15118 3/20 0.67
RAB9A P51151 3/20 0.67
TP53 P04637 3/20 0.67
USP2 O75604 2/20 0.67
POLB P06746 5/20 0.66
HPGD P15428 4/20 0.66
MEN1 O00255 1/20 0.64
LMNA P02545 1/20 0.64
TSHR P16473 1/20 0.64
KMT2A Q03164 1/20 0.64
ESR1 P03372 1/20 0.63
TDP1 Q9NUW8 2/20 0.62
RXFP1 Q9HBX9 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30427273 1.00 KDM4E (0.71) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL17544322 0.88 KDM4E (0.71) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL30426788 0.88 KDM4E (0.71) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL19428571 0.86 KDM4E (0.71) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL30402223 0.85 KDM4E (0.79) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL17543988 0.85 KDM4E (0.79) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL2248127 0.84 KDM4E (0.89) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL17544479 0.84 KDM4E (0.71) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL30402357 0.84 KDM4E (0.71) KDM4EHSD17B10NPSR1MAPTALDH1A1
SCHEMBL2248459 0.83 KDM4E (1.00) KDM4EHSD17B10NPSR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200102328-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2020-04-02 US claimed
US-10479802-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2019-11-19 US claimed
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 US claimed
EP-3186233-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI Foundation, Inc. (US) 2017-07-05 EP claimed
WO-2016033445-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2016-03-03 WO claimed
US-12258355-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2025-03-25 US disclosed
US-12083108-B2 Compounds for targeting mutant huntingtin protein and uses thereof CHDI FOUNDATION, INC. (US) 2024-09-10 US disclosed
CN-116655618-A Probes for imaging huntingtin CHDI基金会股份有限公司 2023-08-29 CN disclosed
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2023-07-06 US disclosed
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2023-07-06 US disclosed
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2023-07-06 US disclosed
CN-107108534-B Probes for imaging huntingtin CHDI基金会股份有限公司 2023-05-09 CN disclosed
US-20200102328-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2020-04-02 US disclosed
US-10479802-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2019-11-19 US disclosed
US-10479802-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2019-11-19 US disclosed
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 US disclosed
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 US disclosed
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 US disclosed
EP-3186233-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI Foundation, Inc. (US) 2017-07-05 EP disclosed
WO-2016033445-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2016-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212190-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 KDM4E 4585/4885HSD17B10 966/4885NPSR1 885/4885
US-12083108-B2 Compounds for targeting mutant huntingtin protein and uses thereof HTT, HYPK, UBQLN2 KDM4E 2698/4885HSD17B10 2464/4885NPSR1 4163/4885
US-10479802-B2 Probes for imaging huntingtin protein HTT, HYPK, FABP7 KDM4E 4674/4885HSD17B10 883/4885NPSR1 818/4885
US-20200102328-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 KDM4E 4585/4885HSD17B10 966/4885NPSR1 885/4885
US-20170283436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, FABP7 KDM4E 4674/4885HSD17B10 883/4885NPSR1 818/4885
US-12258355-B2 Probes for imaging huntingtin protein HTT, HYPK, HSPBP1 KDM4E 4585/4885HSD17B10 966/4885NPSR1 885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.